Movano Inc (MOVE)

$0.39

+0.01

(+1.62%)▲

Market is closed - opens 7 PM, 04 Jun 2024

Insights on Movano Inc

  • Vs BSX

    In the last 1 year, Boston Scientific Corp. has given 45.7% return, outperforming this stock by 108.2%

  • Vs BSX

    In the last 3 years, Boston Scientific Corp. has given 79.6% return, outperforming this stock by 171.9%

Performance

  • $0.38
    $0.42
    $0.39
    downward going graph

    2.28%

    Downside

    Day's Volatility :8.98%

    Upside

    6.85%

    downward going graph
  • $0.35
    $1.50
    $0.39
    downward going graph

    10.26%

    Downside

    52 Weeks Volatility :76.67%

    Upside

    74.0%

    downward going graph

Returns

PeriodMovano IncIndex (Russel 2000)
3 Months
-31.94%
0.0%
6 Months
-51.25%
0.0%
1 Year
-62.14%
0.0%
3 Years
-92.31%
-22.6%

Highlights

Market Capitalization
38.3M
Book Value
- $0.03
Earnings Per Share (EPS)
-0.53
Profit Margin
0.0%
Operating Margin TTM
-675.35%
Return On Assets TTM
-161.27%
Return On Equity TTM
-577.43%
Revenue TTM
852.0K
Revenue Per Share TTM
0.02
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
EBITDA
-28.1M
Diluted Eps TTM
-0.53
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Technicals Summary

Sell

Neutral

Buy

Movano Inc is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Movano Inc
Movano Inc
-14.32%
-51.25%
-62.14%
-92.31%
-94.09%
Stryker Corporation
Stryker Corporation
4.27%
16.65%
22.1%
34.77%
82.03%
Boston Scientific Corp.
Boston Scientific Corp.
4.07%
37.85%
46.89%
79.63%
93.34%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
3.26%
27.0%
2.23%
-8.36%
51.45%
Abbott Laboratories
Abbott Laboratories
-2.62%
-2.21%
-0.86%
-5.87%
32.8%
Medtronic Plc
Medtronic Plc
0.44%
2.96%
-1.92%
-33.69%
-13.02%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Movano Inc
Movano Inc
NA
NA
NA
0.0
-5.77
-1.61
NA
-0.03
Stryker Corporation
Stryker Corporation
38.89
38.89
2.92
11.96
0.19
0.07
0.01
50.33
Boston Scientific Corp.
Boston Scientific Corp.
63.5
63.5
1.8
2.33
0.09
0.05
NA
13.56
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
37.45
37.45
5.19
2.76
0.21
0.12
NA
11.82
Abbott Laboratories
Abbott Laboratories
31.83
31.83
5.99
4.63
0.15
0.06
0.02
22.31
Medtronic Plc
Medtronic Plc
29.48
29.48
1.52
5.2
0.07
0.04
0.03
38.29
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Movano Inc
Movano Inc
NA
$38.3M
-94.09%
NA
0.0%
Stryker Corporation
Stryker Corporation
Buy
$129.9B
82.03%
38.89
16.03%
Boston Scientific Corp.
Boston Scientific Corp.
Buy
$111.1B
93.34%
63.5
12.05%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
Buy
$52.4B
51.45%
37.45
23.01%
Abbott Laboratories
Abbott Laboratories
Buy
$177.8B
32.8%
31.83
13.96%
Medtronic Plc
Medtronic Plc
Buy
$106.7B
-13.02%
29.48
11.36%

Institutional Holdings

  • Dorsey & Whitney Trust CO LLC

    3.82%

  • Vanguard Group Inc

    1.83%

  • Awm Investment Company Inc

    1.37%

  • Raymond James Finl Svs Advisors, Inc.

    0.55%

  • Mirador Capital Partners LP

    0.42%

  • Geode Capital Management, LLC

    0.35%

Company Information

movano is a health-focused technology company that believes glucose is an important health metric to continuously track, as glucose levels serve as a proxy for metabolic health and risk for chronic disease, such as diabetes. we also believe that whether you are a person with diabetes, prediabetes or someone looking to pursue a healthier lifestyle, monitoring and managing your glucose levels shouldn’t be painful, complicated or conspicuous.

Organization
Movano Inc
Employees
30
CEO
Dr. John Mastrototaro Ph.D.
Industry
Miscellaneous

Discover More

FAQs